Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Drug Clinical Trials for Pilocarpine HCI Ophthalmic Solution

About this update from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A

Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Drug Clinical Trials for Pilocarpine HCI Ophthalmic SolutionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Class A